Fibrous dysplasia research is at a critical juncture, facing significant challenges after a halt in federal funding disrupted the study of this rare skeletal disease.Affecting approximately 1 in 15,000 to 30,000 individuals, fibrous dysplasia manifests through benign bone tumors that lead to painful deformities and fractures.